IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
METRONIDAZOLE TOPICAL LIPOSOMAL GEL FOR THE EFFECTIVE TREATMENT OF ROSACEA: A REVIEW

Author: SUBHASREE BHASKAR, SWEETY SAMADDER, SUMIT NAG, SANGITA DAS, SUBHABROTA MAJUMDAR
Abstract: Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, which were first described in the mid 60s by Bangham and Coworkers. The topical liposomal preparations are used for the treatment of rosacea which is a chronic cutaneous disorder affecting primarily the convexities of the central face mostly in the cheek, nose, chin, and central forehead. It is a very common skin disorder in Northern European and Celtic origin between 30 and 50 years of age. It is more common in women, but may be more severe in men. More aggressive and innovative uses of existing oral agents have resulted in novel therapeutic approaches, which can provide long-term therapy and sustained remission. Topical metronidazole has been designated an orphan drug by the FDA for the treatment of rosacea. Different features initiates the formulation of Metronidazole topical liposomal gel for better penetrability and affectivity as compared to the topical gel alone for the better treatment of rosacea.
Keyword: Rosacea, Cutaneous disorder, Phosphatidylcholine, Topical liposome, Metronidazole.
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free